Insights › Market reaction

Why Lexeo Therapeutics (LXEO) Stock Rose 17.20% in 10 Minutes After Q3 Earnings on Nov 16, 2026

EPS of -0.43 came in below the -0.33 estimate.

Published in ET: Feed time in ET: Earnings LXEO +17.20% in 10 min after the headline
  • LXEO rose 17.20% in the 10 minutes after the 07:02:41 ET headline, from $2.99 to $3.50.
  • 417,987 shares changed hands in those 10 minutes.
  • The headline crossed in pre-market trading, 2 hours 28 minutes before the 9:30 ET open.
LXEO Why Lexeo Therapeutics (LXEO) Stock Rose 17.20% in 10 Minutes After Q3 Earnings on Nov 16,
MoveSurge publish 07:02:41 ET
MoveSurge publish
07:02:41 ET
3.73 3.42 3.10 2.79 3.50 07:00 07:02 07:12
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
LXEO 2.99 2.99 3.17 3.50 +6.02% +17.20%

Lexeo Therapeutics (LXEO) shares rose 17.20% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 07:02:41 ET on Monday, November 16, 2026. EPS of -0.43 came in below the -0.33 estimate.

LXEO in the first 10 minutes

The line that crossed at 07:02:41 ET: “LXEO Q3: EPS -0.43 vs -0.33 est”

From a reference price of $2.99 just before the headline, the stock was up 6.02% after one minute and up 17.20%, at $3.50, after 10 minutes. The move kept building after the first minute. 417,987 shares changed hands in those 10 minutes. The headline crossed in pre-market trading, 2 hours 28 minutes before the 9:30 ET open.

Lexeo Therapeutics Q3 results against estimates

MeasureReportedEstimateResult
EPS-0.43-0.33Miss

How LXEO traded after earlier earnings releases

ReportEPS vs estimateRevenue vs estimateFirst move
Aug 12, 2026-0.30 vs -0.28—not measured
May 11, 2026-0.25 vs -0.33—not measured

Lexeo Therapeutics at a glance

SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Market value$239 million (as of Nov 16, 2026)
Next earnings report on the calendarWednesday, November 18, 2026

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

How did Lexeo Therapeutics stock react to its Q3 earnings on November 16, 2026?

The stock rose 17.20% in the 10 minutes after its Q3 results crossed at 07:02:41 ET. EPS of -0.43 came in below the -0.33 estimate.

How far did LXEO move after the headline?

From $2.99 just before the headline to $3.50 10 minutes later, a +17.20% move.

When does Lexeo Therapeutics report earnings next?

The next report on the MoveSurge earnings calendar is Wednesday, November 18, 2026.

Sources

Follow LXEO live

The live feed pairs breaking headlines with measured price moves. Build a watchlist of stocks you own and choose whether matching news reaches your WhatsApp.

Open the live feed See portfolio WhatsApp alerts
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.